The collapse of talks between Greece and its creditors sent the markets tumbling with the Dow plunging 130 points to 17,768. Nasdaq dropped 26 points to 5,024.
On the upside
RedHill Biopharma (Nasdaq: RDHL) reported positive results from a Phase III study of RHB-105 to treat H. pylori infection.
Shares of Anthera Pharmaceuticals (Nasdaq: ANTH) continued rising.
The Wall Street Journal reported that Anthem (NYSE: ANTM) offered to acquire Cigna (NYSE: CI).
On the downside
Canaccord Genuity analyst John Newman cut his price target on Agios Pharmaceuticals (Nasdaq: AGIO) from $103 to $93.
Profit taking weighed down shares of Leju Holdings (NYSE: LEJU).
Investors locked in profits on E-Commerce China Dangdang (NYSE: DANG).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 fell 10 points to 2083. Bitcoin added $3 to $236.
